Sunnyvale, CA November 3, 2014 – The custom technologies arm of Molecular Devices, a leader in bioanalytical systems for drug discovery, life science research, and bioassay development, has partnered with the Discovery Technologies team at the Roche… Read More
Molecular Devices Introduces Microplate Reader and Washer Sunnyvale, California, April 26, 2014 - Molecular Devices® today at the Experimental Biology annual meeting in San Diego introduced the inexpensive and versatile EMax® Plus Microplate Reader and… Read More
Sunnyvale, California, April 2, 2014 - Molecular Devices® today announced the launch of the EarlyTox™ Cell Integrity Kit, a fast, simple, and reliable fluorescence-based assay for detecting changes in cell viability based on permeability of outer cell… Read More
Sunnyvale, CA, JANUARY 21, 2014 - Molecular Devices announced that its ClonePixTM 2 System is proven effective for rapidly assessing endogenous G-protein-coupled receptor (GPCR) target protein expression levels in mammalian cell lines and selecting high… Read More
Sunnyvale, CA, December 3 2013 - Molecular Devices®, the market leader in microplate reader technology for over 25 years, has announced today the next-generation SpectraMax® MiniMax™ 300 Imaging Cytometer. This MiniMax 300 imaging cytometer enables both… Read More
Sunnyvale, California, October 16, 2013 - Molecular Devices® announced today the launch of the ScanLater™ Western Blot Detection System. The first of its kind system combines western blot membrane detection with a multimode microplate reader platform,… Read More
Sunnyvale, California, September 24, 2013 - Molecular Devices® announced today the launch of ImageXpress® Micro XLS System, the latest improvement to its high content screening portfolio. Developed as a single wide-field integrated system with unlimited… Read More
Sunnyvale, California, September 18, 2013 - Molecular Devices® today announced the launch of the EarlyTox™ Cardiotoxicity Kit, a fast, simple and reliable fluorescence-based kit for identifying cardiotoxicity of drug candidates early in the discovery… Read More
PORT WASHINGTON, N.Y., September 16, 2013 — ForteBio, a division of Pall Life Sciences and a leading supplier of instrumentation for accelerated drug discovery and development, today announced the launch of the Octet® HTX system, the new flagship member… Read More
New reagent kit combines Fura-2 dye with Molecular Devices' masking technology to offer improved ease of use and data quality Sunnyvale, California, August 19, 2013 - Molecular Devices® today announced the launch of its Fura-2 QBTTM Calcium Kit. This new… Read More